<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="Research Article" dtd-version="1.0"><front><journal-meta><journal-id journal-id-type="pmc">iarjimph</journal-id><journal-id journal-id-type="pubmed">IARJIMPH</journal-id><journal-id journal-id-type="publisher">IARJIMPH</journal-id><issn>2709-331X</issn></journal-meta><article-meta><article-id pub-id-type="doi">https://doi.org/10.47310/iarjimph.2025.v06i01.014</article-id><title-group><article-title>Changes In Serum Levels of Calcitonin Gene-Related Peptide in Pregnant Women with Gestational Diabetes Mellitus</article-title></title-group><abstract>Background: Gestational diabetes mellitus (GDM) is the impaired carbohydrate metabolism first diagnosed in pregnancy, which may lead to serious health problems for the mother and her fetus. Aim: The aim of this study was to&amp;nbsp;determine calcitonin gene-related peptide (CGRP) levels in pregnant women with GDM. In addition, it was aimed to determine whether serum CGRP level is associated with adiponectin level. Patients and Methods: The case-control study was carried out in Tikrit city (Salah&amp;nbsp;Al-Din General Hospital) from 15th&amp;nbsp;of January&amp;nbsp;to the end&amp;nbsp;of December 2022. The number of pregnant women understudy were 100 women in the 3rd&amp;nbsp;trimester of pregnancy whose ages were between 20-45 years old who attended&amp;nbsp;Salah&amp;nbsp;Al-Din General Hospital /Obstetric part. The study also included 50 healthy non-diabetic pregnant women in 3rd trimester of pregnancy ages were between 20-45 years as control group. Medical information, such as maternal age, gravida, parity,&amp;nbsp;number of abortions, reproductive&amp;nbsp;and&amp;nbsp;medical&amp;nbsp;history&amp;nbsp;was&amp;nbsp;obtained from patient ﬁles.&amp;nbsp;Blood samples were collected&amp;nbsp;for assessment of HbA1c, blood sugar,&amp;nbsp;calcitonin gene-related peptide (CGRP) and adiponectin levels. Results:&amp;nbsp;The study showed&amp;nbsp;the mean of CGRP was elevated significantly in GDM group (8.04 pg/ml) compared with women without GDM control group&amp;nbsp;(2.91 pg/ml) (P:0.001). The study showed&amp;nbsp;the mean of adiponectin was reduced significantly in GDM group (77.89) compared with women without GDM control group (99.72 pg/ml) (P:0.001). It was found that HbA1c was elevated significantly in GDM women (5.91%) and the lowest mean was non-GDM women (5.21%) and fasting blood sugar was also elevated significantly in GDM women (135.3 mg/dl) and the lowest mean was non-GDM women (91.35 mg/dl). The study showed positive correlation of CGRP serum level with each of&amp;nbsp;FBS, HbA1c&amp;nbsp;and Gestational&amp;nbsp;age&amp;nbsp;and&amp;nbsp;negative correlation with serum Adiponectin among women with gestational diabetes. Conclusions: Serum&amp;nbsp;CGRP&amp;nbsp;levels&amp;nbsp;were increased significantly&amp;nbsp;inpregnant&amp;nbsp;women with&amp;nbsp;GDM&amp;nbsp;compared with women without GDM control group and the&amp;nbsp;outcomes of&amp;nbsp;this&amp;nbsp;investigation suggest&amp;nbsp;that&amp;nbsp;high&amp;nbsp;CGRP&amp;nbsp;levels&amp;nbsp;in pregnant women may be a pivotal&amp;nbsp;role in the&amp;nbsp;natural history&amp;nbsp;of GDM.</abstract></article-meta></front><body /><back /></article>